Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

NEXUS PHARMACEUTICALS, LLC — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

NEXUS PHARMACEUTICALS, LLC

via DLA PIPER LLP (US)

3rd Quarter (July 1 - Sep 30) · 2024Posted Oct 21, 2024Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: NEXUS PHARMACEUTICALS, LLC
Description: Pharmaceutical company
Location: Illinois · United States of America

Registrant

Firm: DLA PIPER LLP (US)
Description: Law firm.
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Advocating for regulatory enforcement of pharmacy compounders manufacturing approved drug products.
LobbyistsMARGARET MARTIN
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.